Prelude
PRLD
Prelude (PRLD) news
Recent news
Prelude's PRT13722 phase 1 trial to start enrolling 4Q
AInvest Wire · 1d agoPrelude Therapeutics Incorporated - Maintains full global development and commercial rights to PRT13722
AInvest Wire · 1d agoPrelude Therapeutics Incorporated - Expects to begin enrollment for phase 1 trial in Q4 2026
AInvest Wire · 1d agoPrelude Therapeutics Incorporated - Agreement supports evaluation of PRT13722 with abemaciclib and imlunestrant in phase 1 trial
AInvest Wire · 1d agoInpex Corp: Inpex to acquire minority share in Browse
Japan’s INPEX has acquired a 40% participating interest in the offshore WA-502-P block in Western Australia, following the 2013 Australian Offshore Petroleum Acreage Release. The permit was granted to INPEX Browse E&P Pty Ltd, a subsidiary of INPEX, with Santos retaining a 60% stake and operating…
AInvest Wire · May 15, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.